Ying-Ying Huang

Ying-Ying Huang

Auto-generated profile, based on publicly available information

Ying-Ying Huang

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2011 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
HCHoon Chung
Hoon Chung
TDTianhong Dai
Tianhong Dai
SSSulbha K. Sharma
Sulbha K. Sharma
YHYing-Ying Huang
Ying-Ying Huang
JCJames D Carroll
James D Carroll
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin

1 September 2009 in Dose-Response
Verified
Journal Article
Open access
YHYing-Ying Huang
Ying-Ying Huang
ACAaron C.-H. Chen
Aaron C.-H. Chen
JCJames D Carroll
James D Carroll
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
The use of low levels of visible or near infrared light for reducing pain, inflammation and edema, promoting healing of wounds, deeper tissues and nerves, and preventing cell death and tissue damage has been known for over forty years since the invention of lasers. Despite many reports of positive findings from experiments conducted in vitro, in animal models and in randomized controlled clinical trials, LLLT remains controversial in mainstream medicine. The biochemical mechanisms underlying the positive effects are incompletely understood, and the complexity of rationally choosing amongst a large number of illumination parameters such as wavelength, fluence, power density, pulse structure and treatment timing has led to the publication of a number of negative studies as well as many positive ones. A biphasic dose response has been frequently observed where low levels of light have a much better effect on stimulating and repairing tissues than higher levels of light. The so-called Arndt-Schulz curve is frequently used to describe this biphasic dose response. This review will cover the molecular and cellular mechanisms in LLLT, and describe some of our recent results in vitro and in vivo that provide scientific explanations for this biphasic dose response.

1 July 2011 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
TDTianhong Dai
Tianhong Dai
MTMasamitsu Tanaka
Masamitsu Tanaka
YHYing-Ying Huang
Ying-Ying Huang
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
Since its discovery approximately 200 years ago, chitosan, as a cationic natural polymer, has been widely used as a topical dressing in wound management owing to its hemostatic, stimulation of heal...

1 September 2009 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
TDTianhong Dai
Tianhong Dai
YHYing-Ying Huang
Ying-Ying Huang
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin

1 August 2014 in Recent Patents on Anti-Infective Drug Discovery
Verified
Journal Article
Closed access
PDF file
FSFelipe F. Sperandio
Felipe F. Sperandio
YHYing-Ying Huang
Ying-Ying Huang
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
Antimicrobial photodynamic therapy (PDT) or photodynamic inactivation (PDI) is a new promising strategy to eradicate pathogenic microorganisms such as Gram-positive and Gram-negative bacteria, yeasts and fungi. The search for new approaches that can kill bacteria but do not induce the appearance of undesired drug-resistant strains suggests that PDT may have advantages over traditional antibiotic therapy. PDT is a non-thermal photochemical reaction that involves the simultaneous presence of visible light, oxygen and a dye or photosensitizer (PS). Several PS have been studied for their ability to bind to bacteria and efficiently generate reactive oxygen species (ROS) upon photo-stimulation. ROS are formed through type I or II mechanisms and may inactivate several classes of microbial cells including Gram-negative bacteria such as Pseudomonas aeruginosa, which are typically characterized by an impermeable outer cell membrane that contains endotoxins and blocks antibiotics, dyes, and detergents, protecting the sensitive inner membrane and cell wall. This review covers significant peer-reviewed articles together with US and World patents that were filed within the past few years and that relate to the eradication of Gram-negative bacteria via PDI or PDT. It is organized mainly according to the nature of the PS involved and includes natural or synthetic food dyes; cationic dyes such as methylene blue and toluidine blue; tetrapyrrole derivatives such as phthalocyanines, chlorins, porphyrins, chlorophyll and bacteriochlorophyll derivatives; functionalized fullerenes; nanoparticles combined with different PS; other formulations designed to target PS to bacteria; photoactive materials and surfaces; conjugates between PS and polycationic polymers or antibodies; and permeabilizing agents such as EDTA, PMNP and CaCl2. The present review also covers the different laboratory animal models normally used to treat Gram-negative bacterial infections with antimicrobial PDT.

23 August 2011 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
GKGitika B. Kharkwal
Gitika B. Kharkwal
SSSulbha K. Sharma
Sulbha K. Sharma
YHYing-Ying Huang
Ying-Ying Huang
TDTianhong Dai
Tianhong Dai
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin